无视网膜病变的2型糖尿病患者的黄斑神经与微血管改变:一项SS-OCT研究
前瞻性横断面研究纳入49例无临床可见视网膜病变的2型糖尿病患者与51例年龄匹配对照,采用扫频源光学相干断层扫描(SS-OCT)血管成像定量分析黄斑各视网膜层厚度及不同毛细血管丛的血管指标。糖尿病患者黄斑神经节细胞-内丛状层(GC-IPL)和视网膜神经纤维层(RNFL)厚度显著降低,全毛细血管丛血管骨架密度也出现细微改变。作者认为黄斑RNFL和GC-IPL厚度是早期检出糖尿病视网膜病变的较优指标,但需进一步研究。
要点
- 无视网膜病变的2型糖尿病患者黄斑GC-IPL厚度为82.5±5.5 µm,低于年龄匹配对照的86.2±5.0 µm(P = .001)。
- 黄斑RNFL厚度为45.8±3.0 µm,低于对照的48.1±3.7 µm(P = .001);全视网膜厚度为324.9±16.3 µm,低于对照的332.8±13.7 µm(P = .009)。
- 全毛细血管丛黄斑血管骨架密度为0.132±0.005,低于对照的0.135±0.005(P = .019)。
核心结论
- SS-OCT衍生的指标,尤其是黄斑RNFL和GC-IPL厚度,是早期检出无临床可见视网膜病变的2型糖尿病患者糖尿病视网膜病变的较优指标。
- 作者认为需进一步研究以全面理解这些发现的临床意义。
研究设计与样本
- 前瞻性横断面研究,纳入49例无临床可见视网膜病变的2型糖尿病患者和51例年龄匹配对照。
- 所有眼均使用PLEX Elite 9000行扫频源光学相干断层扫描(SS-OCT)血管成像,定量分析黄斑各视网膜层厚度及不同毛细血管丛的黄斑血管指标。
主要发现
- 糖尿病患者黄斑GC-IPL平均厚度为82.5±5.5 µm,低于年龄匹配对照的86.2±5.0 µm(P = .001)。
- 糖尿病患者黄斑RNFL厚度为45.8±3.0 µm,低于年龄匹配对照的48.1±3.7 µm(P = .001)。
- 糖尿病患者黄斑全视网膜厚度为324.9±16.3 µm,低于年龄匹配对照的332.8±13.7 µm(P = .009)。
- 糖尿病患者全毛细血管丛黄斑血管骨架密度为0.132±0.005,低于年龄匹配对照的0.135±0.005(P = .019)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 作者在结论中认为需进一步研究以全面理解这些发现的临床意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To identify specific markers indicative of macular neural and microvascular alterations in individuals with Type 2 Diabetes Mellitus (T2DM) without clinically observable retinopathy. DESIGN: Prospective cross-sectional study. METHODS: Using the PLEX Elite 9000, all eyes underwent swept-source optical coherence tomography (SS-OCT) angiography. Quantitative analysis of acquired images compared macular neural and microvascular alterations in T2DM patients without retinopathy to age-matched controls. Precise assessments encompassed measuring the thickness of each individual retinal layer and evaluating macular vascular indices within different capillary plexuses. RESULTS: Forty-nine T2DM patients and 51 age-matched controls participated. T2DM patients exhibited a significant reduction in the mean macular thickness of the ganglion cell-inner plexiform layer (GC-IPL) (82.5 ± 5.5 µm vs 86.2 ± 5.0 µm, P = .001) and macular retinal nerve fiber layer (RNFL) (45.8 ± 3.0 µm vs 48.1 ± 3.7 µm, P = .001). Furthermore, macular full retinal thickness was significantly lower in diabetic eyes than controls (324.9 ± 16.3 µm vs 332.8 ± 13.7 µm, P = .009). Vascular measurements revealed subtle changes in macular vascular skeleton density within the total capillary plexuses in T2DM patients (0.132 ± 0.005 vs 0.135 ± 0.005, P = .019). CONCLUSIONS: Metrics derived from SS-OCT, particularly macular RNFL and GC-IPL thicknesses, emerged as superior indicators for the early detection of diabetic retinal disease in individuals with T2DM without clinically observable retinopathy. Further investigations are warranted to comprehensively understand the clinical implications of these findings.
引用
- Dai Y, Zheng D, Zhao J, et al. Macular Neural and Microvascular Alterations in Type 2 Diabetes Without Retinopathy: A SS-OCT Study. Am J Ophthalmol. 2024. PMID: 38428559. doi:10.1016/j.ajo.2024.02.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。